Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO
|
7 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
BREAST CANCER, SUSCEPTIBILITY TO
|
24 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
8 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Li-Fraumeni Syndrome 2
|
11 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
PROSTATE CANCER, SUSCEPTIBILITY TO
|
6 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Mantle cell lymphoma
|
19 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2002 | 2002 | |||||
Hereditary pancreatitis
|
108 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2003 | 2003 | |||||
Colon Carcinoma
|
275 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Malignant neoplasm of kidney
|
22 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Malignant tumor of colon
|
688 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.710 | 1.000 | 1 | 2004 | 2004 | |||||
Prostate cancer, familial
|
25 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Renal carcinoma
|
21 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
Carcinoma, Lobular
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1 | 2005 | 2005 | ||||||
Cystadenoma
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Malignant neoplasm of ovary
|
315 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.710 | 1.000 | 1 | 2006 | 2006 | |||||
Malignant neoplasm of prostate
|
1082 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2004 | 2008 | |||||
Prostate carcinoma
|
1168 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2004 | 2008 | |||||
Malignant neoplasm of gastrointestinal tract
|
55 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||
Endometrial Carcinoma
|
326 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.710 | 1.000 | 1 | 2009 | 2009 | |||||
Malignant neoplasm of endometrium
|
197 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Malignant neoplasm of pancreas
|
277 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Pancreatic carcinoma
|
322 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Adult Hodgkin Lymphoma
|
27 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Childhood Hodgkin Lymphoma
|
29 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 |